Publications by authors named "Victoria Calzada"

Claim this Profile
A
Aptamer-Based Immunotheranostic Strategies.
María Fernanda García Melián, María Moreno, Hugo Cerecetto, Victoria Calzada

Cancer Biother Radiopharm· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted-Lymphoma Drug Delivery System Based on the Sgc8-c Aptamer.
Estefanía Sicco, Hugo Cerecetto, Victoria Calzada, María Moreno

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Evaluation of Sgc8-c Aptamer as a Molecular Imaging Probe for Colon Cancer in a Mouse Xenograft Model.
Ana Paula Arévalo, Romina Castelli, Manuel Ibarra, Martina Crispo, Victoria Calzada

Int J Mol Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T908 Polymeric Micelles Improved the Uptake of Sgc8-c Aptamer Probe in Tumor-Bearing Mice: A Co-Association Study between the Probe and Preformed Nanostructures.
Romina Castelli, Manuel Ibarra, Ricardo Faccio, Iris Miraballes, Marcelo Fernández, Victoria Calzada

Pharmaceuticals (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequence-dependent structural properties of B-DNA: what have we learned in 40 years?
Gabriela da Rosa, Leandro Grille, Victoria Calzada, Katya Ahmad, Juan Pablo Arcon

Biophys Rev· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic and non-metastatic melanoma imaging using Sgc8-c aptamer PTK7-recognizer.
Estefanía Sicco, Amy Mónaco, Marcelo Fernandez, María Moreno, Victoria Calzada

Sci Rep· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aptamers in Diagnostic and Molecular Imaging Applications.
Victoria Calzada

Adv Biochem Eng Biotechnol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sgc8-c Aptamer as a Potential Theranostic Agent for Hemato-Oncological Malignancies.
Estefanía Sicco, Jessica Baez, Manuel Ibarra, Marcelo Fernández, Pablo Cabral, Victoria Calzada

Cancer Biother Radiopharm· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivatizations of Sgc8-c aptamer to prepare metallic radiopharmaceuticals as imaging diagnostic agents: Syntheses, isolations, and physicochemical characterizations.
Estefanía Sicco, Jessica Báez, Jimena Margenat, Fernanda García, Manuel Ibarra, Victoria Calzada

Chem Biol Drug Des· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for Melanoma.
Ximena Camacho, Victoria Calzada, Marcelo Fernandez, Omar Alonso, Roger Chammas

Curr Radiopharm· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fab(nimotuzumab)-HYNIC-99mTc: Antibody Fragmentation for Molecular Imaging Agents.
Victoria Calzada, María Fernanda García, Luis Michel Alonso-Martínez, Ximena Camachoc, Enzo Goicochea

Anticancer Agents Med Chem· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of new PTK7-targeting aptamer-fluorescent and -radiolabelled probes for evaluation as molecular imaging agents: Lymphoma and melanoma in vivo proof of concept.
Victoria Calzada, María Moreno, Jessica Newton, Joel González, Marcelo Fernández

Bioorg Med Chem· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microwave-assisted synthesis of HYNIC protected analogue for 99mTc labeled antibody.
María F García, Victoria Calzada, Ximena Camacho, Enzo Goicochea, Juan Pablo Gambini

Curr Radiopharm· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[(99m)Tc(CO)(3)]-radiolabeled bevacizumab: in vitro and in vivo evaluation in a melanoma model.
Ximena Camacho, María Fernanda García, Victoria Calzada, Marcelo Fernández, Jose A Chabalgoity

Oncology· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of (99m)Tc chelate-conjugated bevacizumab.
Ximena Camacho, María Fernanda García, Victoria Calzada, Marcelo Fernández, Williams Porcal

Curr Radiopharm· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Labeling and Biological Evaluation of (99m)Tc-HYNIC-Trastuzumab as a Potential Radiopharmaceutical for In Vivo Evaluation of HER2 Expression in Breast Cancer.
Victoria Calzada, Fernanda Garcia, Marcelo Fernández, Williams Porcal, Thomas Quinn

World J Nucl Med· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potencial theranostic agent for EGF-R expression tumors: (177)Lu-DOTA-nimotuzumab.
Victoria Calzada, Xiuli Zhang, Marcelo Fernandez, Arlhee Diaz-Miqueli, Normando Iznaga-Escobar

Curr Radiopharm· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of 99mTc-nimotuzumab with tricarbonyl ion: in vitro and in vivo studies.
Maria Fernanda Garcia, Ximena Camacho, Victoria Calzada, Marcelo Fernandez, Williams Porcal

Curr Radiopharm· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis